SG11201804670PA - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds - Google Patents

Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Info

Publication number
SG11201804670PA
SG11201804670PA SG11201804670PA SG11201804670PA SG11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA SG 11201804670P A SG11201804670P A SG 11201804670PA
Authority
SG
Singapore
Prior art keywords
sfl
lioz
alp
tof
uopdaiatd
Prior art date
Application number
SG11201804670PA
Other languages
English (en)
Inventor
Craig Bates
David P Reed
Original Assignee
Arqule Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule Inc filed Critical Arqule Inc
Publication of SG11201804670PA publication Critical patent/SG11201804670PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201804670PA 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds SG11201804670PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562268747P 2015-12-17 2015-12-17
PCT/US2016/067164 WO2017106642A1 (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Publications (1)

Publication Number Publication Date
SG11201804670PA true SG11201804670PA (en) 2018-07-30

Family

ID=59057612

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804670PA SG11201804670PA (en) 2015-12-17 2016-12-16 Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds

Country Status (19)

Country Link
US (3) US9981921B2 (cg-RX-API-DMAC7.html)
EP (2) EP3390369B1 (cg-RX-API-DMAC7.html)
JP (2) JP2018537499A (cg-RX-API-DMAC7.html)
KR (1) KR20180086508A (cg-RX-API-DMAC7.html)
CN (1) CN108368061A (cg-RX-API-DMAC7.html)
AU (2) AU2016369523B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018012095A2 (cg-RX-API-DMAC7.html)
CA (1) CA3006081A1 (cg-RX-API-DMAC7.html)
EA (2) EA202091691A1 (cg-RX-API-DMAC7.html)
ES (1) ES2935818T3 (cg-RX-API-DMAC7.html)
HK (1) HK1256825A1 (cg-RX-API-DMAC7.html)
IL (1) IL259556B2 (cg-RX-API-DMAC7.html)
MX (2) MX385671B (cg-RX-API-DMAC7.html)
NZ (1) NZ742695A (cg-RX-API-DMAC7.html)
PH (2) PH12018501246A1 (cg-RX-API-DMAC7.html)
SA (1) SA518391805B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201804670PA (cg-RX-API-DMAC7.html)
TW (2) TWI796250B (cg-RX-API-DMAC7.html)
WO (1) WO2017106642A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017106642A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
MX2020012771A (es) 2015-12-17 2022-10-04 Arqule Inc Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma
JP7641247B2 (ja) 2022-03-02 2025-03-06 日立建機株式会社 機械の性能診断装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU5330698A (en) * 1996-12-23 1998-07-17 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
EP1790634A3 (en) * 2003-06-18 2007-06-13 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal form and processes for preparing it
CA2710051C (en) * 2006-12-29 2017-05-16 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
CN102325755B (zh) * 2008-12-30 2015-07-01 艾科尔公司 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物
JP5808818B2 (ja) * 2010-11-25 2015-11-10 ラツィオファーム・ゲーエムベーハー アファチニブの新規塩及び多形形態
WO2012177852A1 (en) 2011-06-24 2012-12-27 Arqule, Inc Substituted imidazopyridinyl compounds
US9802954B2 (en) * 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
WO2013044816A1 (en) * 2011-09-30 2013-04-04 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan and preparation and uses thereof
WO2017106642A1 (en) * 2015-12-17 2017-06-22 Arqule, Inc. Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
MX2020012771A (es) * 2015-12-17 2022-10-04 Arqule Inc Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida.
US9847831B2 (en) 2016-04-08 2017-12-19 Ciena Corporation Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system

Also Published As

Publication number Publication date
AU2022201947A1 (en) 2022-04-14
US20200002293A1 (en) 2020-01-02
MX2018007414A (es) 2018-11-09
MX385671B (es) 2025-03-18
CA3006081A1 (en) 2017-06-22
MX2021000432A (es) 2022-07-28
IL259556B2 (en) 2023-09-01
EP3390369A4 (en) 2019-08-14
TW202241854A (zh) 2022-11-01
BR112018012095A2 (pt) 2018-11-27
AU2016369523A1 (en) 2018-06-07
EA036295B1 (ru) 2020-10-22
EP4019499A1 (en) 2022-06-29
JP2022031797A (ja) 2022-02-22
IL259556A (en) 2018-07-31
EA201891430A1 (ru) 2018-11-30
TWI796250B (zh) 2023-03-11
NZ742695A (en) 2022-10-28
US10717710B2 (en) 2020-07-21
US9981921B2 (en) 2018-05-29
PH12020551465A1 (en) 2021-07-26
US10227311B2 (en) 2019-03-12
AU2022201947B2 (en) 2023-07-27
SA518391805B1 (ar) 2022-12-21
US20170174636A1 (en) 2017-06-22
PH12018501246A1 (en) 2019-02-04
MX394320B (es) 2025-03-24
JP2018537499A (ja) 2018-12-20
TWI771280B (zh) 2022-07-21
TW201736352A (zh) 2017-10-16
EP3390369B1 (en) 2022-11-02
EP3390369A1 (en) 2018-10-24
WO2017106642A1 (en) 2017-06-22
HK1256825A1 (zh) 2019-10-04
EA202091691A1 (ru) 2021-01-29
IL259556B1 (en) 2023-05-01
AU2016369523B2 (en) 2021-12-23
US20180258055A1 (en) 2018-09-13
KR20180086508A (ko) 2018-07-31
CN108368061A (zh) 2018-08-03
ES2935818T3 (es) 2023-03-10

Similar Documents

Publication Publication Date Title
DE112010001831B4 (de) Steuerverfahren für ein Beleuchtungssystem und Beleuchtungssystem
SG11201804935TA (en) Apparatus and method for fabricating an object
SG11201809276QA (en) N-((heteroarylmethyl)-heteroaryl-carboxamide derivatives as plasma kallikrein inhibitors
JP2016504275A5 (cg-RX-API-DMAC7.html)
WO2008118820A3 (en) Somatic cell reprogramming
EP1619929A3 (de) Hörhilfegerätesystem sowie Verfahren zum Betrieb eines Hörhilfegerätesystems bei Audio-Empfang
EP2028882A3 (en) Remote audio monitoring system for amplifiers in a network
EP2868518A3 (en) Slip-responsive vehicle drive system
WO2011065800A3 (ko) 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
WO2008117707A1 (ja) オルメサルタンメドキソミルの粉砕結晶
EP2837268A1 (de) Beleuchtungssystem und steuereinheit hierfür
EP2665346A3 (de) Vorrichtungen und Verfahren zur Phasenwahl für eine Leuchte
EP1728550A4 (en) Method for producing coated fine particles
MX2009001315A (es) Compuestos de dimetilciclobutilo substituidos, su preparación y uso en medicamentos.
EP3106002B1 (de) Beleuchtungssystem und verfahren zum betrieb eines beleuchtungssystems mit integriertem sicherheitskonzept
FR2933226B1 (fr) Procede et systeme de production d'oeuvres audiovisuelles
GEP20115332B (en) Herbal composition for inflammatory disorders
CN204317004U (zh) 一种新型烟草移栽机
EP3147264A3 (en) Systems and methods for mechanically combining loose scrap
EP2270947A3 (de) Vorrichtung zur Energieverteilung und Verfahren
EP2236673A3 (de) Flächenrütteleinrichtung
WO2009121618A1 (de) Beleuchtungsanordnung mit mehreren separaten beleuchtungseinheiten
DE102015120686A1 (de) Flurförderzeug mit einer tragbaren Funkbedieneinheit sowie Verfahren zur Bedienung eines Flurförderzeugs aus der Entfernung mit einer tragbaren Funkbedieneinheit
CN113940156A (zh) 一种石灰石矿排土场生态修复用的植被种植装置
DE102013204479A1 (de) Beleuchtungssystem und Verfahren zum Steuern eines Beleuchtungssystems